Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-07-25

Clinical Trial Update: Evaluation of Analgesia With EMLA and Glucose Oral Solution [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluated analgesia using EMLA topical cream in combination with a glucose oral solution, and the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EMLA Cream (lidocaine 2.5% / prilocaine 2.5% topical cream)
  • Glucose Oral Solution (dextrose oral solution)

Snippet

Sponsor: Federal University of Minas Gerais | Conditions: Pain | Phase 4 | Status: COMPLETED